Novel Chimeric Antigen Receptor Design Technology for CAR-T Cells Published and Licensed Exclusively to Cellinfinity Bio
WEST HAVEN, Conn. & SAN FRANCISCO--(BUSINESS WIRE)--Jul 27, 2023--
Source: eagletribune.com
📰 Cellinfinity Bio News
Cellinfinity Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cellinfinity Bio. Real-time updates on events, politics, business and more.
Novel gene delivery technology published and licensed exclusively to Cellinfinity Bio
WEST HAVEN, Conn. & SAN FRANCISCO--(BUSINESS WIRE)--Jul 10, 2023--
Source: eagletribune.com
Novel gene delivery technology published and licensed exclusively to Cellinfinity Bio
MAJESTIC technology allows CRISPR-independent, DNA-free and non-lentiviral gene delivery into diverse cell types with high efficiency and cell viabilityCellinfinity has exclusively licensed the technology for development of next-generation genetically enhanced cell therapyWEST HAVEN, Conn. & SAN FRANCISCO--(BUSINESS...
Cellinfinity Bio Premal Patel Sidi Chen Yale University Nature Biomedical Engineeringon July Professor Sidi Chen
Source: pharmiweb.com
Astellas and MBC BioLabs Announce 2022 Future Innovator Prize Awarded to Bespoke Biotherapeutics and Cellinfinity Bio
/PRNewswire/ -- Astellas Venture Management LLC (President: William Watt, Ph.D., "AVM"), a wholly-owned venture capital subsidiary of Astellas Pharma Inc....
Source: prnewswire.com
Astellas and MBC BioLabs Announce 2022 Future Innovator Prize Awarded to Bespoke Biotherapeutics and Cellinfinity Bio
/PRNewswire/ -- Astellas Venture Management LLC (President: William Watt, Ph.D., "AVM"), a wholly-owned venture capital subsidiary of Astellas Pharma Inc....
Source: prnewswire.com